Literature DB >> 225272

Antibody responses and interferon titers in the respiratory tracts of mice after aerosolized exposure to influenza virus.

Y C Zee, J W Osebold, W M Dotson.   

Abstract

We studied the temporal appearance of immunoglobulins (immunoglobulins G1, G2, M, and A) and interferon in lung lavage fluids of mice after aerosol exposure to influenza virus in six animal groups in which mortality rates ranged from 0 to 24%. Immunoglobulin levels in the lung lavage fluids were markedly higher in mouse groups with higher mortality rates (16, 20, and 24%) than in those with low mortality rates (0, 2.5, and 7.5%). Analysis of serum albumin in the respiratory secretions as an index of edema indicated that increased immunoglobulin G levels during the early phase of infection were due to increased vascular permeability. The detection of virus-neutralizing antibodies and antibodies reactive with influenza virus antigens in the lavage fluids at 6 to 8 days postinfection suggested local immunoglobulin synthesis as a result of antigenic stimulation. Both systemic and local antibody productions contributed to immunoglobulin levels in the respiratory secretions after aerosolized influenza virus infection. Peak levels of interferon in the lavage fluids were reached before detection of significant levels of virus-neutralizing antibody in the serum or the lung lavage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225272      PMCID: PMC414438          DOI: 10.1128/iai.25.1.202-207.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Immunoelectrophoresis of nasal secretions collected during a common cold: observations which suggest a mechanism of seroimmunity in viral respiratory infections.

Authors:  T O ANDERSON; L J RIFF; G G JACKSON
Journal:  J Immunol       Date:  1962-11       Impact factor: 5.422

2.  FURTHER OBSERVATIONS ON IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINE BY INHALATION.

Authors:  Y OKUNO
Journal:  Arch Gesamte Virusforsch       Date:  1965

3.  Role of interferon in recovery from virus infections.

Authors:  A ISAACS; G HITCHCOCK
Journal:  Lancet       Date:  1960-07-09       Impact factor: 79.321

4.  Responses of mice immunized with influenza virus by serosol and parenteral routes.

Authors:  G H Scott; R J Sydiskis
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

5.  The effects of ozone on the respiratory epithelium and alveolar macrophages of mice. I. Interferon production.

Authors:  A L Ibrahim; Y C Zee; J W Osebold
Journal:  Proc Soc Exp Biol Med       Date:  1976-09

6.  Virus multiplication and interferon formation in lungs from mice infected with A2 influenza virus.

Authors:  F Link; D Blaskovic; J Raus
Journal:  Acta Virol       Date:  1965-07       Impact factor: 1.162

7.  Response of canine fetuses and neonates to antigenic stimulation.

Authors:  M Shifrine; J B Smith; M S Bulgin; B J Bryant; Y C Zee; B I Osburn
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

8.  Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.

Authors:  J C Perkins; D N Tucker; H L Knope; R P Wenzel; R B Hornick; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

9.  Specific response of the immunoglobulins to rubella infection.

Authors:  J V Baublis; G C Brown
Journal:  Proc Soc Exp Biol Med       Date:  1968-05

10.  Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.

Authors:  T Iwasaki; T Nozima
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

View more
  8 in total

1.  Pathogenesis of bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (Sendai) virus.

Authors:  W L Castleman; L J Brundage-Anguish; L Kreitzer; S B Neuenschwander
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

2.  Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus.

Authors:  S L Owens; J W Osebold; Y C Zee
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

3.  Hemagglutinin-specific antibody responses in immunoglobulin G, A, and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus.

Authors:  D B Burlington; M L Clements; G Meiklejohn; M Phelan; B R Murphy
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

Review 4.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

5.  Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection.

Authors:  P R Wyde; M R Wilson; T R Cate
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  The relation of interferon and nonspecific inhibitors to virus levels in nasal washes of ferrets infected with influenza viruses of differing virulence.

Authors:  R H Husseini; C Sweet; M H Collie; H Smith
Journal:  Br J Exp Pathol       Date:  1981-02

7.  Exposure to ozone reduces influenza disease severity and alters distribution of influenza viral antigens in murine lungs.

Authors:  J A Wolcott; Y C Zee; J W Osebold
Journal:  Appl Environ Microbiol       Date:  1982-09       Impact factor: 4.792

8.  Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant.

Authors:  Vinay Saluja; Jean P Amorij; Maarten L van Roosmalen; Kees Leenhouts; Anke Huckriede; Wouter L J Hinrichs; Henderik W Frijlink
Journal:  AAPS J       Date:  2010-01-08       Impact factor: 4.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.